In this week’s View, Dr. Eagle looks at cardiac rehabilitation for people with heart failure. He then discusses managing cardiovascular (CV) disease in cancer survivors who have completed cancer ...

Disparities in life expectancy, driven by race, geography, socioeconomic status and systemic inequities, have widened alarmingly – from a 12.6-year gap in 2000 to a staggering 20.4 years by 2021 in ...

BMI = body mass index; CVD = cardiovascular disease; DM = diabetes mellitus; HDL = high-density lipoprotein; IFN = interferon; NET = neuroendocrine tumor; SLE = systemic lupus erythematosus. The high ...

The Centers for Medicare and Medicaid Services (CMS) has temporarily reassigned coronary CT angiography (CCTA) codes 75572-75574 from ambulatory payment classification (APC) 5571 to APC 5572 in the ...

Secondary prevention medications for cardiovascular diseases are underused globally and additional strategies to increase their use are needed to improve management and reduce premature mortality ...

Secondary prevention medications for cardiovascular diseases (CVD) are underused globally and additional strategies to increase their use are needed to improve CVD management and reduce premature ...

Days alive out of health care and hospitalization (DAoH), a novel measure of outcomes in children undergoing cardiovascular surgery, offers advantages over the traditional outcome measure of days ...

The ACC has issued new guidance on practical approaches for arrhythmia monitoring after stroke, offering clinicians tailored strategies to improve post-stroke care by identifying and managing atrial ...

MedAxiom recently released the 2024 Cardiovascular Advanced Practice Provider (APP) Compensation and Utilization Report, which shows how APP leadership roles are beginning to guide new team-based care ...

The ULTIMATE-DAPT (One-Month Ticagrelor Monotherapy After PCI in Acute Coronary Syndromes) trial data demonstrated that, in patients with acute coronary syndrome who underwent percutaneous coronary ...

Cardiovascular medications frequently lead the polypharmacy category, often contributing to adverse clinical outcomes, and the most vulnerable among us are often prescribed the most complex regimens.

In this episode of Conversations with Critical Care Cardiologists, we dive into the evolving landscape of education and training in Critical Care Cardiology (CCC). As this specialty rapidly advances, ...